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Abstract
In recent years, great advances have been made towards the development of various techniques for novel drug delivery systems. These techniques focus on the rate of drug delivery, duration of action and site of action. One of such
technique in fabricating novel drug delivery system is the use of polymers in development of in-situ drug delivery
systems. Polymers used as carriers have revolutionized over the years. The formation of a polymer complex with other
oppositely charged polymers resulted in the formation of polyelectrolyte complexes, which possess unique physicochemical properties with high biocompatibility. The polyelectrolyte's themselves are characterized as cationic, anionic
and non-ionic according to the nature of the functional group present at the polymer chain, type of macromolecules
formed and interaction forces existing between the complex formed. Additionally, these natural complexes avoid the use
of chemical agents for cross linking of polymeric chains, thereby limiting toxicity. Due to their sustain and convenient
way to deliver highly water soluble drugs they could target therapeutically active moiety to the site of action, and for
these reasons they have led to various applications in the biomedical sector, in pharmaceutical and nano biotechnology
industries. Thereby the use of polymers in in-situ drug delivery offers many beneﬁts because of their sustained and
prolonged drug delivery action when compared with other conventional drug delivery systems. The present review
focuses on the use of natural Polymers in polyelectrolyte complexes as a drug delivery technology.
Keywords: Sustained release, Natural polymers, Polyelectrolyte, Drug delivery technology

1. Introduction

V

arious new approaches and advancements
have been made in novel drug delivery
systems. The new approaches implemented so far
focuses on better and highly novel techniques for
targeting drugs at speciﬁc site of action [1].
One such advancement is the use of polymers as
drug carriers especially in in-situ drug delivery
systems. The complex forms between oppositely
charged polymeric material results in formation of
polyelectrolyte complexes. The polymer is known to
play an active role in sustained and controlled
release of the drug. Since different polymers possess
different physicochemical properties, they are usually incorporated as coating material, ﬁlm forming

agent, drug carrier, granulating agent, excipient in
tablet formation and as solubilising agents. The role
of polymers in drug delivery accelerates by undergoing phase transition in response to an external
stimulus such as change in temperature, electric
potential, pH and ionic strength.
This systems are considered to play a vital role for
achieving sustained release of drug due to their
favourable properties of water solubility, biodegradability, biocompatibility, non-toxicity [2].
The polyelectrolyte complexes (PEC) are formed
due to the electrostatic interaction between the
opposite charged polymers/poly-ions. Such interaction limits toxicity as well as undesirable side effects. Priory this charge to charge interaction
between ionic polymers and drugs were not
considered to be useful, but now due to the
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advancement in research and exploitation of these
interactions they are considered to be very useful
and give highly successful results in all of the new
approaches developed so far [3].
With the development of in-situ polymeric drug
delivery systems, it has enhanced the ease of
administration of drugs, limited dose frequency as
well as improved patient compliance. As such,
various cationic and anionic polymers have been
used so far in the development of in-situ drug delivery systems. Depending upon the route of
administration these systems have been classiﬁed
into the following parts:
a) In-situ forming polymeric systems for oral
administration.
b) In- situ forming polymeric systems for ocular
delivery.
c) In-situ forming injectable drug delivery system.
d) In-situ forming polymeric systems for rectal and
vaginal delivery.
e) In-situ forming nasal drug delivery system.
1.1. Polyelectrolytes
The polyelectrolytes are polymers that contain a
negative and a positive charge at neutral pH [4]. They
are formed by strong electrostatic interactions between oppositely charged polyelectrolyte's, leading
to inter polymer ionic condensation as well as release
of counter ions simultaneously. These Polyelectrolyte
complex (PEC) tend to combine the physicochemical
properties of at-least two of the polyelectrolyte's
being used. And they easily get dissociated in water
as well as they are considered to be highly soluble due
to the electrostatic interaction between the polymer
and the charged monomers [5].
1.2. Classiﬁcation of polyelectrolytes
The polyelectrolyte's are considered to be both
organic as well as inorganic, as they exhibit both the
properties such as ﬂocculation and de-ﬂocculation.
The coagulants exhibiting sedimentation property
in low molecular weight synthetic polymers are
considered as inorganic polyelectrolyte's. While the
ones exhibiting this property in high molecular
weight synthetic polymers are considered as organic
polyelectrolyte's (Table 1).
The classiﬁcation is as follows:
a) Based on the origin:
1) Synthetic polyelectrolytes e poly (styrene sulfonic
acid),
poly
(acryl
alkyl
trialkyl

Table 1. Natural polymers in formation of polyelectrolyte complex.
Name

Natural polyelectrolytes
Nuclei acids
Poly (L-lysine)
Poly (L-glutamic acid)
Carageenan
Alginates
Hyaluronic acid
Chemically modiﬁed biopolymers
Pectin
Chitosan (deacetylation of chitin)
Cellulose-based
Starch-based
Dextran-based
Synthetic polyelectrolytes
Poly (vinylbenzyl trialkyl ammonium)
Poly (4-vinyl-N-alkyl-pyridimiun)
Poly (acryloyl-oxyalkyl-trialkyl ammonium)
Poly (acryamidoalkyl-trialkyl ammonium)
Poly (diallydimethyl-ammonium)
Poly (styetenesulfonic acid)
Poly (vinylsulfonic acid)
Poly (acrylic or methacrylic acid)
Poly (itaconic acid)
Maleic acid/diallyamine copolymer

Category
(based on the
charge type)
Polyanion
Polycation
Polyanion
Polyanion
Polyanion
polyanion
Polyanion
Polycation
Polyanion or
Polycation
Polyanion or
Polycation
Polyanion or
Polycation
Polycation
Polycation
Polycation
Polycation
Polycation
Polyanion
Polyanion
Polyanion
Polyanion
Poly-ampholytic

ammonium),poly (vinyl benzene tri alkyl ammonium), poly (vinyl sulfonic acid), poly (acrylic or
methacrylic acid).
2) Chemically modiﬁed polymers - Pectin, chitin,
cellulose based, dextran based.
3) Natural polyelectrolytes e Nucleic acids,
carrageenan, alginates.
b) Based on charge:
1) Anionic (negatively charged) e When the
charge carried by active portion of the polymer is
negative it is termed as anionic. These are produced by ionisation of acrylic acid unit of a
polymer. Examples are Polyacrylamides (homo/
co polymers of Na salt of acrylic acids with
acrylamide).
2) Cationic (positively charged) - When the
charge carried by active portion of the polymer is
positive it is termed as cationic. Here, the nitrogen parts of the polymer posses the positive
charge. They are available in wide range
depending upon the cationic monomer present,
the charge density and the molecular weight.
Examples are homo/co polymers with acrylamide
of three major cationic monomers.
3) Non-ionic (no charge) e When no charge is
present on the active portion of the polymer it is
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termed as non-ionic. Examples are, large homopolymers of acrylamide with wide range of molecular weights [6,7].
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interactions. These are insoluble in ordinary solvents and the molar ratio is almost unity (Fig. 1) [8].

2. Structural models of PEC's
1.3. Mechanism of formation of PEC’S
The PEC's are obtained by three step process e
1) Primary complex formation
2) Formation within intra-complexes
3) Intra-complex aggregation
1.3.1. Primary complex formation
This is the 1st step towards the formation of PEC's
which is governed by coulombs forces. It is a rapid
process where the mixing between oppositely
charged polyelectrolyte's takes place.
1.3.2. Formation within intra-complexes
This second step towards the formation of PEC's is
the formation of intra-complexes which proceeds
after half an hour from the initial ﬁrst step. New
bonds are formed and distorted polymeric chains
are modiﬁed.
1.3.3. Intra-complex aggregation
This is the ﬁnal step towards the formation of
PEC's in which the intra-complexes formed in the
2nd step, undergoes aggregation via hydrophobic

There are three different types of structures that
are
formed
during
polycationepolyanion
interaction.
i) Water soluble
ii) Colloidal stable
iii) Two phase system
2.1. Water soluble
The water-soluble aggregates formed consist of
long host molecules complexes in an orderly
manner with shorter poly-ions of opposite charge.
These are formed when polyelectrolytes with weak
ionic groups and large differences in molar mass are
mixed in a non-stoichiometric ratio. (The ratio between cationic and anionic groups must be > 1 or <1
but not ¼ 1). Their stability is affected by concentration of soluble salts and ratio of charge between
the two polyelectrolyte's [9].
2.2. Colloidal stable
The colloidal stable PEC's can be obtained by
inhibiting the formation of water-soluble PEC's

Fig. 1. Schematic Representation of mechanism of formation of polyelectrolytes.
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which results in highly aggregated and macroscopically heterogeneous system due to complex formation between high or moderately high molecular
weight polyelectrolyte's. This can be inhibited by
using extremely diluted solution of a low or moderate ionic strengths at non-stoichiometric conditions [10].

2.5. Factors affecting polyelectrolyte complexes
While mixing two oppositely charged polyelectrolytes it causes separation of polymer richphase (milky phase) from Polymer depleted-phase
(clear phase) (Table 2) [18,19].
a) Structure parameters

2.3. Two phase system

 Charge-to-charge stoichiometry

The two phase system comprises of a liquid phase
and a PEC's rich phase which can be obtained by
mixing highly concentrated solutions of high and
similar molecular weight polyelectrolytes within
stoichiometric ratios. The rheological properties of
these electrolytes depends on the properties of
polyelectrolyte's and their salt concentrations [11].
2.4. Preparation of polyelectrolytre complexes
For the preparation of polyelectrolyte complex
solution two oppositely charged polyelectrolytes are
taken and dispersed in a dispersion medium (usually deionized water) at various concentrations and
at deﬁned stoichiometric ratios. In order to get the
required ionic strength, a poly salt such as sodium
chloride is added and the pH is ﬁnally adjusted. The
solutions are then ﬁltered through 0.22m Millipore
membrane [12,13].
2.4.1. PEC formation and particle reﬁnement
The PEC's are either polycation or polyanion
prepared at room temperature. The complex formation process is done by the slow addition of
polyanionic solution (dropwise) at a controlled rate
to a polycationic solution of same strength [14]. It
can also be done by constant magnetic stirring with
one-shot addition of one of the polyelectrolyte solution to the oppositely charged polyelectrolyte solution possessing the same ionic strength [15]. In
case of particle reﬁnement, this process is carried
out through centrifugation process, but it is important to avoid physiosorption of the free polymers
onto the surface of already formed PEC's. The ﬁnal
product is usually suspended in a minimum volume
of deionised water [16,17].

It is the ratio of positive to negative charge of the
oppositely charged polyelectrolytes involved in the
formation of PEC's and is denoted as Z with subscripts (þ/ or /þ). Their stoichiometry is denoted
by F [20]. The polyelectrolytes formed are considered to be hydrophobic and precipitate from the
aqueous solution when Stochiometric-PEC's (F ¼ 1),
while if Non Stochiometric -PEC's (F ¼ 1) then it
results in overcharging effect due to the presence of
either excess of polycation or polyanion [21e23].
 Charge density
This parameter was explained using cationic and
anionic copolymers of acrylamide by Dautzenberg
et al., (1997). They observed that when equal charge
density is present on the polyelectrolytes it forms a
compact structure while if the system contain strong
deviating charge density then it results in loose
ﬂuctuating structure [24].
 Molecular weight
The molecular weight of the polyelectrolyte is
directly proportional to its particle size. If the molecular weight of polyelectrolytes is increased it results in an increased particle size. Therefore larger
the chain more likely the positively charged electrolytes will complex with negatively charged ones
[25].
b) Media parameters
 Polyelectrolyte concentration
The concentration of polyelectrolytes is directly
proportional to the particle size and inversely

Table 2. Illustrative representation of various factors affecting the formation of PEC's.
Structural parameters

Media parameters

Preparation parameters

Charge- to- charge stoichiometry
Charge density
Molecular weight of polyelectrolytes

Polyelectrolyte concentration
pH of reaction medium
Salt concentration

Mode of mixing of polyelectrolytes
Order of mixing of polyelectrolytes
Mixing ratio
Duration of interaction
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proportional to electrostatic repulsion occurring
between them. The dispersive interaction between
polyelectrolytes could be elevated by increasing the
concentration of the polyelectrolytes which reduces
the electrostatic repulsion between them and results
in increment of particle size per volume [26].
 The pH
The pH plays a role in particle size and the nature
of coagulation. It is directly proportional to the size
of the particles and if value of pH is decreased it
would resulted to decreased particle size. While
considering charged particles, if PEC's comprise of
highly charged particles with lower pH values they
will show lesser amount of coagulation due to
mutual electrostatic repulsion, whereas if they
possess low charged particles having high pH level
they will show coagulation due to electrostatic
attraction existing between them [27].
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to avoid aggregation. The rapid one-shot mixing
procedure is considered beneﬁcial over the slow
dropwise mixing as the former gives PEC's of
smaller diameter and high stability [28].
 Mixing ratio
The mixing ratio is inversely proportional to particle size and molecular weight. When the mixing
ratio is increased in a saltless system it causes a
decrease in the molecular weight as well as decrease
in the particle size of the PEC's. Some studies
showed that in case of a salted system, due to the
presence of salts, there is a considerable increase in
the particle size and decrease in the amount of aggregation between the particles [29].
2.6. The use of polymers in in-situ polymeric drug
delivery system

c) Preparation parameters

This system offers sustained and controlled
release of the drug with a better therapeutic
outcome. The in situ polymeric formulation used in
drug delivery is basically present in solution form
before being administered into the body. Upon
administration, it undergoes gelation to form gel.
There are various factors which affect the formation
of gel these include pH change, temperature modulation, ultra-violet irradiation and presence of ions.
The polymers used for this purpose include gellan
gum, alginic gum, xyloglucan, pectin, chitosan, poly
(DL-lactic acid), poly (DL-lactide-co-glycolide and
poly-caprolactone. The choice of solvent to be used
depends on the nature of solubility of the polymer
being used. These preparations formed can be used
in oral, rectal, vaginal, injectable and intraperitoneal
routes [30,31].

 Mode of mixing of polyelectrolyte solutions

A) In situ oral drug delivery system

 Salt concentration
The effect of salt concentration on the properties
of PEC's can be studied either during complexation
or after complexation. It has been observed that the
particle size of PEC's considerably increases on
increasing the salt concentration and even favours
coagulation [28].
 Ionic strength
The ionic strength of polyelectrolyte's is inversely
proportional to its size. So with an increase in ionic
size it decreases the average size and thereby induces an increase in chain ﬂexibility.

The mixing of polycation and polyanion for the
preparation of polyelectrolytes depends on factors
such as the kind of mixing done, the mixing protocol
and the type of device used. For low molecular
weight polyelectrolytes smaller PEC's are obtained
at shorter mixing times whereas in case of polyelectrolytes with high molecular weight the size of
PEC's are decreased initially with shorter mixing
time and then increased by increasing the mixing
time [12,28].
 Order of addition
The order of addition of polyelectrolytes is
considered to be an important parameter as the
polymer existing as default must be added in excess

In oral drug delivery system pectin, xyloglucan
and gellan gum are the natural polymers used for in
situ polymeric drug delivery system. The pectin is a
natural anionic polymer used in in situ oral drug
delivery system. The polymer backbone comprises
of a-(1e4)-D-galacturonic acid. The polymer readily
forms gel in aqueous solution in the presence of
calcium since the calcium ions present in the
formulation form a crosslink with galacturonic acid
chain in an egg-box model. Similarly sodium citrate
can be added to pectin to form a complex with the
calcium ions present in the formulation, this allows
the formulation to be in a ﬂuid state (sol) on
administration, until the complex is broken down
when it comes in contact with the acidic
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environment of the stomach, where the release of
calcium ions initiates gelation. Since it is water soluble and no other organic solvents are required for
the formulation it is therefore considered as an ideal
system for sustained drug delivery. Example, Paracetamol has been formulated as in situ gelling pectin
[32].
Kwasaki N et al., studied on xyloglucan as a
vehicle for oral drug delivery system. Xyloglucan is
natural non-ionic polymer, It is a polysaccharide
obtained from tamarind seeds and comprises of
(1e4)- b-D-glucan as backbone chain which consist
of (1e6)- a-D xylose branches partially substituted
by (1e2)- b-D-galactoxylose [33]. This polymer undergoes thermally reversible gelation when it is
partially degraded by b-galactosidase through the
lateral stacking of the rod like chains. It forms gel at
much lower concentration since the solution to gel
transition depends on the degree of galactose
eliminated. Apart from its use in oral drug delivery
it has been found useful in ocular, intraperitoneal
and rectal drug delivery systems [34,35].
Gellan gum it is an anionic deacetylated exocellular polysaccharide secreted by Pseudomonas
elodea consisting tetra-saccharide repeating unit of
one a-L-rhamnose, one b-D-glucuronic acid and two
b-D-glucuronic acid [36,37]. This polymer undergoes
gelation which is temperature and cations mediated.
The gelation results in a double helical junction
zone followed by aggregation of the double helical
segment to form three-dimensional network by
complexing with cations and forming hydrogen
bonds with water [38e40]. Example: It has been
used as a vehicle for oral drug delivery of theophylline in which the formulation comprises of gellan
solution complexed with calcium chloride and sodium citrate [41,42]. During oral administration the
calcium ions get released in the acidic environment
of the stomach causing gelation [43,44].
B) In situ ocular drug delivery system
The in situ based ocular drug delivery is carried
out using natural polymers such as gellan gum,
alginic acid, and xyloglucan. This method has been
considered beneﬁcial and more sufﬁcient than other
conventional drug delivery system and is often been
used for the delivery of antimicrobial agents, antiinﬂammatory agents and autonomic drugs for the
treatment of glaucoma [45].
The aqueous solution of Gellan gum has been
used here for release of the medication into the eye,
upon administration due to temperature difference
as well as the ionic condition of the tissue ﬂuid the
solution phase is converted to gel phase [46,47].

Alginic acid is an anionic linear block copolymer
polysaccharide comprising of b-D-mannuronic acid
and a-L-glucuronic acid residues attached to 1,4glycosdic linkage. The arrangement within the
molecules vary depending on the algal source. This
polymer undergoes gelation on addition of di-and
trivalent metal ions through a process involving
formation of glucuronic residues from the a-L-glucuronic acid of the alginate chain. It has been
considered as a vehicle for ophthalmic formulations,
as it exhibits properties such as biodegradability,
mucoadhesive character and non-toxicity [48].
Carbopol is a pH dependent polymer. At acidic
pH it stays in solution form while in alkaline pH it
forms a gel [49,50]. Hydroxy-propyl-methylcellulose
is often used in combination with Carbopol, this is
because here it aids the Carbopol by reducing the
acidity of the system thus imparting viscosity which
is enough to induce sufﬁcient alkalinity to change in
gel form. Example: Indomethacin for the treatment
of uveitis has been formulated by this concept.
Sustained release of the drug for a period of 8 hours
in vitro was observed and considered better than
other conventional methods [51,52].
Miyazaki et al., conducted studies on rabbit eye
and formulated in situ gels for the ocular delivery of
pilocarpine hydrochloride using xyloglucan as the
polymer and it showed a signiﬁcant mitotic
response for a period of 4 hours when instilled into
the lower cul-de-sac portion of rabbit eye [53].
C) In situ vaginal and reactal drug delivery system
Various in situ gel formulations have been developed for drug delivery though vaginal and rectal
route. Miyazaki et al., studied the rectal drug delivery of indomethacin with the use of xyloglucan
based thermo-reversible gels. This formulation was
subjected to rabbits and it showed a higher drug
absorbance peak. Signiﬁcant decrease in Cmax and a
longer residence time of the drug with the ability of
being non-toxic to the nervous system [54].
Bilensoy E et al., proposed a study for prolonging
the treatment of vaginitis where he prepared
vaginal gel comprising clotrimazole-beta-cyclodextrin complexed with pluronic F-127 in situ polymer
along with Carbopol and hydroxy-methylcellulose,
which showed longer residence time of the drug
thus improving its therapeutic efﬁcacy [55].
D) In situ injectable drug delivery system
Various polymers are being used with the development of in-situ polymeric drug delivery system.
Chitosan is one such cationic polymer that is being
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Table 3. List of Studies illustrating the sustained release of drugs through in situ gels.
Drug

Polymer used

Route of
administration

Results

Doxorubicin [29]

Human serum albumin
and tartaric acid derivative
Poly lactide-c-glycolide
Poly-lactic acid and PLGA
Polyacrylic acid and
polymethacrylic acid
Physically cross- linked
dextran

Injectable

Sustained delivery of anticancer drug for a prolonged
period of time 0.100 hours
Controlled release of proteins.
A controlled zero order in-vitro release was observed.
Sustained delivery of pheniramine for 2 days and of
albumin-FTIC for 5 days.
Drug loaded hydrogel releases drug over a period of
5 days, shows excellent biodegradability and
biocompatibility.
Sustained oral delivery

Proteins [30]
Testosterone [31]
Phenaramine maleate and
albumin FTIC [32]
Recombinant human
interleukin [31]

Injectable
Injectable
Injectable
Injectable

Paracetamol and
Ambroxol [32]
Theophylline [33]

Pectin

Oral

Gellan gum

Oral

Indomethacin [34]

Xyloglucan

Rectal

Clotrimazole [35]]

Pluronic F-127,
Carbopol 934, HPMC
Gellan gum and
xanthan gum

Vaginal

Mometasone furoate [36]

Nasal

used for this speciﬁc drug delivery system, it is a
bio-degradable, thermosensitive, polycationic polymer obtained by alkaline deacetylation of chitin
which is a natural component of shrimp and crab
shell. This polymer usually exists as solution form at
a pH of 6.2, on neutralization of its aqueous solution
the pH exceeds 6.2 and it then leads to the formation
of a hydrated gel-like precipitate. The polyol salts
bearing a single anionic head such as glycerol, sorbitol, fructose or glucose phosphate salts are added
to the chitosan aqueous solution to form a thermally
sensitive pH dependent gel forming solution. This
transformation limits its bio-degradability problem
[56]. Example: This formulation has been used to
deliver biologically active growth factors in vivo
which turns into gel implants in situ in living
chondrocytes for tissue engineering applications.
Another example for studies conducted on mice for
tumour treatment where a thermo-sensitive in situ
gelling hydrogel consisting paclitaxel was developed which consisted chitosan solution neutralized
with b-glycerophosphate. It was found to be effective as it inhibited the growth of EMT-6 cancer cells
in mice in a less toxic manner [57].
Zhang et al., developed thermoplastic plates for
the local delivery of taxol from a thermoplastic triblock copolymer system composed of poly (D,Llactide)-block-poly (ethylene glycol)-block-poly
(D,L-lactide) blended with low molecular weight
poly (D,L-lactide) and poly (e-caprolactone) PCL.
This formulation was injected in the form of solution

Four- ﬁve fold increase of bioavailability in rats and
threefold increase in rabbits on comparison with
commercial oral formulations.
Broad drug absorption peak and a longer residence
time when compared to commercial products.
Controlled release of drug was achieved.
Inhibits the increase in nasal symptoms when
compared with commercial formulations.

which then got converted to form a semisolid gel
mass upon cooling at body temperature. The
melting points of these polymers are greater than
60 . because of which when administered it has the
same temperature and it causes pain and chances of
necrosis as well as scar at the site of injection to the
patient. It therefore was not considered of much use
[58].
Dardanoo et al., developed PCL as polymeric
paste with a molecular weight of 10e20 KDa to
overcome the problems associated with the slow
release of the above mentioned taxol. For this he
used various water-soluble additives such as
gelatin, albumin, methylcellulose, dextran and sodium chloride to enhance its release. These additives were mixed with taxol, pulverized and then
added to molten containing low molecular weight
PCL. The in vivo drug release and anti-angiogenic
activity of the in-situ systems were studied using
chorio-allantoic membrane. The results showed rate
of swelling to be higher. Thus, the paste prepared
using taxol-gelatin swelled at a faster rate and these
additives increased the water imbibition thereby
resulting in better dissolutions as well as drug
release and this model also induced angiogenesis
inhibition [59].
Sawhney et al., developed a photopolymerizable
biodegradable hydrogel, as a tissue containing the
drug as well as a controlled release carrier. This
system comprises of a macromer (PEG-oligoglycolyl-acrylate), a photosensitive initiator (eosin dye)
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and a light source (UV or visible light). Upon
exposure to light this system undergoes photopolymerization to form a network example argon
laser. Further it can be employed for the release of
water-soluble drugs and enzymes at a controlled
rate [60].
E) In situ nasal drug delivery system
Cao S et al., developed an in situ gel for mometasone furoate for the treatment of allergic rhinitis
using xanthan gum and gellan gum as polymers and
conducted animal studies using allergic rhinitis
model and also studied the effect of in situ on antigen induced sensitized rats, which showed an effect
by inhibiting the increase in nasal symptoms when
compared with other marketed products. It showed
the presence of normal goblet cells and an intact
ciliated respiratory epithelium in rats nasal cavity
which ensured its safety proﬁle [56].
Wu et al., developed a new thermosensitive
hydrogel for insulin using N-[(2-hydroxy-3-methyltrimethylammonium)propyl]chitosan chloride and
poly (ethylene glycol) along with a small amount of
alpha-beta-glycerophosphate. This solution transformed to gel at a temperature of 37  C. The animal
studies conducted showed a decline in bloodglucose level by 40e50% for about 4e5 hours after
administration without any toxicity (Table 3) [61].

3. Conclusion
In conclusion, the foremost requirement of any
drug is to show patient compliance with effective
controlled release of the drug giving an excellent
therapeutic outcome, which is currently being
shown with the use of in situ gels. With the
advancement and diverse use of polymers including
water-soluble polymers, in-situ gels could be used
for the sustained release of various drugs. They are
providing number of advantages over conventional
dosage forms, such as better stability, biocompatibility, sustained and prolonged release of the drug.
This makes it more reliable and efﬁcient source of
drug delivery system.
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